SAMANTHA RICKARD: Open Payments
NPI 1558030288 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 37 payments from 19 companies in 2025. Trend: 2023 $2,044 · 2024 $2,085 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $89 |
| SK Life Science, Inc. | 3 | $84 |
| UCB, Inc. | 3 | $84 |
| MDD US Operations, LLC | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Globus Medical, Inc. | 2 | $57 |
| Lundbeck LLC | 3 | $56 |
| Lilly USA, LLC | 3 | $54 |
| ABBVIE INC. | 2 | $37 |
Products named: EPIDIOLEX, AUSTEDO XR, INGREZZA, Rystiggo, VYEPTI, KISUNLA, Symbravo, PANZYGA.
Industry payments across AL — which companies pay providers there.
